4b - Riassunto in atti di congresso

4b - Riassunto in atti di congresso: [10904] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.381 a 1.400 di 10.904

A comparison of the prophylactic use of teicoplanin or cefazolin in the prevention of infections complications of hip and knee prosthesis insertion

1993 Periti P, Stringa G, Mazzei T, Mini E, Novelli A, Calviani L

Pharmacokinetics and blister fluid penetration of ticarcillin/clavulanate in adults

1993 Novelli A, Mazzei T, Mini E, Cassetta MI, Fallani S, Periti P

Effect of the l and d stereoisomers of 5-formyltetrahydrofolate (LV) and 5-methytetrahydrofolate (5-CH3-H4PteGlu) on fluoropyrimidine cytotoxicity in human leukemic CCRF-CEM cells

1994 Mini E, Mazzei T, Carotti S, Coronnello M, Gerli A, Pesciullesi A, Periti P

Mechanisms of resistance to methotrexate (MTX) in human tumors and pharmacological strategies for its circumvention

1994 Mini E, Mazzei T, Periti P

Biochemical modulation of 5-fluorouracil in the treatment of colorectal cancer

1994 Mini E; Tonelli F

Antimicrobial prophylaxis in prosthetic joint implant surgery: a comparative multicenter trial between teicoplanin and cefazolin

1994 Periti P, Stringa G, Mazzei T, Mini E, Dentico P

Pharmacokinetics of melphalan n (L-PAM) in true and mild hyperthermic perfusion in patients with melanoma of the lower limb. A preliminary report

1995 Bellacci A, Pesciullesi A, Galli A, Carlà V, Mini E, Mazzei T, Pace M

Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a Multicenter Study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano.

1995 Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Mazzoni P, Dentico P

Adjuvant chemotherapy with 5-fluorouracil (5-FU) and folinic acid (L-LV) for colorectal carcinoma: preliminary results of a randomized multicenter study of the Gruppo Cooperativo Oncologico Tosco-Umbro (GCOTU)

1995 Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Nobili S, Mazzoni P

Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer

1998 Mini E, Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Rossi S, Tonelli F, Cortesini C, Mazzei T

Gold(III) compounds as potential antitumor agents: cytotoxicity and DNA binding of some selected gold(III) complexes

1998 Carotti S, Guerri A, Mazzei T, Messori L, Mini E, Orioli P

Quantitation of intratumoral thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression by the Polymerase Chain Reaction (PCR): marked variation among human colorectal cancer patients

1998 Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Rossi S, Tonelli F, Cortesini C, Mazzei T, Mini E

Economic evaluation alongside The Pan-European Trial in Adjuvant Colon Cancer (PETACC-1)

1999 Bigdeli M, Apolone G, Torri V, Bedenne L, Bianco AR, Carrato A, Kerr D, Labianca R, Mini E, Paillot B, Pignatti F, Vincent M, Wils J

Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1

2001 Caciagli B, Carotti S, Landini I, Morganti M, Nobili S, Coronnello M, Jansen G, Peters GJ, Toffoli G, Priest DG, Mini E

Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery

2001 Mini E, Grassi F, Cherubino P, Periti P

Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles

2008 Luceri C, Castagnini C, Bigagli E, Toti S, Landini I, Napoli C, Nobili S, Mini E, Dolara P

Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer

2008 Napoli C, Nobili S, Morganti M, Landini I, Cianchi F, Valanzano R, Tonelli F, Mazzei T, Mini E

In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles

2008 Landini I, Napoli C, Nobili S, Morganti M, Rigacci L, Bosi A, Mini E

Thymidylate synthase and orotate phosphoribosyl-transferase gene expression and genotype as predictors for clinical outcome in colorectal cancer patients treated with 5-fluorouracil

2008 Vignoli M, Nobili S, Napoli C. Putignano AL, Morganti M, Papi L, Mini E, Genuardi M

The clinical role of PIK3CA mutations in colorectal cancer

2008 Pratesi N, Simi L, Sestini R, Nobili S, Vignoli M, Landini I, Cianchi F, Valanzano R, Genuardi M, Mini E, Orlando C

Titolo	Data di pubblicazione	Autore(i)
A comparison of the prophylactic use of teicoplanin or cefazolin in the prevention of infections complications of hip and knee prosthesis insertion	1993	Periti P, Stringa G, Mazzei T, Mini E, Novelli A, Calviani L
Pharmacokinetics and blister fluid penetration of ticarcillin/clavulanate in adults	1993	Novelli A, Mazzei T, Mini E, Cassetta MI, Fallani S, Periti P
Effect of the l and d stereoisomers of 5-formyltetrahydrofolate (LV) and 5-methytetrahydrofolate (5-CH3-H4PteGlu) on fluoropyrimidine cytotoxicity in human leukemic CCRF-CEM cells	1994	Mini E, Mazzei T, Carotti S, Coronnello M, Gerli A, Pesciullesi A, Periti P
Mechanisms of resistance to methotrexate (MTX) in human tumors and pharmacological strategies for its circumvention	1994	Mini E, Mazzei T, Periti P
Biochemical modulation of 5-fluorouracil in the treatment of colorectal cancer	1994	Mini E; Tonelli F
Antimicrobial prophylaxis in prosthetic joint implant surgery: a comparative multicenter trial between teicoplanin and cefazolin	1994	Periti P, Stringa G, Mazzei T, Mini E, Dentico P
Pharmacokinetics of melphalan n (L-PAM) in true and mild hyperthermic perfusion in patients with melanoma of the lower limb. A preliminary report	1995	Bellacci A, Pesciullesi A, Galli A, Carlà V, Mini E, Mazzei T, Pace M
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a Multicenter Study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano.	1995	Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Mazzoni P, Dentico P
Adjuvant chemotherapy with 5-fluorouracil (5-FU) and folinic acid (L-LV) for colorectal carcinoma: preliminary results of a randomized multicenter study of the Gruppo Cooperativo Oncologico Tosco-Umbro (GCOTU)	1995	Tonelli F, Periti P, Mazzei T, Mini E, Ficari F, Valanzano R, Nobili S, Mazzoni P
Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer	1998	Mini E, Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Rossi S, Tonelli F, Cortesini C, Mazzei T
Gold(III) compounds as potential antitumor agents: cytotoxicity and DNA binding of some selected gold(III) complexes	1998	Carotti S, Guerri A, Mazzei T, Messori L, Mini E, Orioli P
Quantitation of intratumoral thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression by the Polymerase Chain Reaction (PCR): marked variation among human colorectal cancer patients	1998	Biondi C, Morganti M, Napoli C, Mazzoni P, Cianchi F, Rossi S, Tonelli F, Cortesini C, Mazzei T, Mini E
Economic evaluation alongside The Pan-European Trial in Adjuvant Colon Cancer (PETACC-1)	1999	Bigdeli M, Apolone G, Torri V, Bedenne L, Bianco AR, Carrato A, Kerr D, Labianca R, Mini E, Paillot B, Pignatti F, Vincent M, Wils J
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1	2001	Caciagli B, Carotti S, Landini I, Morganti M, Nobili S, Coronnello M, Jansen G, Peters GJ, Toffoli G, Priest DG, Mini E
Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopedic surgery	2001	Mini E, Grassi F, Cherubino P, Periti P
Comparative genomic hybridization study of genetic changes associated with 5-fluorouracil resistance in HCT-8 colon cancer cell lines: correlations with the expression profiles	2008	Luceri C, Castagnini C, Bigagli E, Toti S, Landini I, Napoli C, Nobili S, Mini E, Dolara P
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer	2008	Napoli C, Nobili S, Morganti M, Landini I, Cianchi F, Valanzano R, Tonelli F, Mazzei T, Mini E
In vitro activity of folate antagonists against methotrexate-resistant CCRF-CEM human T-leukemia sublines and relationships with folate pathway gene expression profiles	2008	Landini I, Napoli C, Nobili S, Morganti M, Rigacci L, Bosi A, Mini E
Thymidylate synthase and orotate phosphoribosyl-transferase gene expression and genotype as predictors for clinical outcome in colorectal cancer patients treated with 5-fluorouracil	2008	Vignoli M, Nobili S, Napoli C. Putignano AL, Morganti M, Papi L, Mini E, Genuardi M
The clinical role of PIK3CA mutations in colorectal cancer	2008	Pratesi N, Simi L, Sestini R, Nobili S, Vignoli M, Landini I, Cianchi F, Valanzano R, Genuardi M, Mini E, Orlando C

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 1.381 a 1.400 di 10.904

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext8389
open1402
reserved1104
partially open6
embargoed3